Entrepreneur clinic
Accelerate Business Growth
Header Ads
Home
Companies
Lupin posts Q3 loss of Rs 152 crore on litigation over blood pressure drug
Lupin posts Q3 loss of Rs 152 crore on litigation over blood pressure drug
03:13
Lupin reported a one-time charge of Rs 342 crore in Q3
from Companies http://bit.ly/2TzQNiy
Lupin posts Q3 loss of Rs 152 crore on litigation over blood pressure drug
Reviewed by
abid
on
03:13
Rating:
5
No comments:
Subscribe to:
Post Comments ( Atom )
Social
187,255
Follow us on
Facebook
60,968
Follow us on
Twitter
11,695
Subscribe us on
YouTube
Facebook
Recent
4/recentposts
Popular
German cabinet to hold secret session on Huawei#39;s role in 5G network: Report
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
Samunnati eyes more than 50% growth in revenue at Rs 6600 cr in FY24
Open agri network Samunnati is eyeing over 50 per cent growth in revenue at Rs 6,600 crore in 2023-24, on the back of deepening its reach in...
My Health Privacy Policy
Privacy Policy Effective date: December 09, 2019 My Health ("us", "we", or "our") operates the https://w...
Tata Steel asks LGBTQ employees to declare partners, avail HR benefits
With its vision to provide equal opportunity to the employees, it has been an endeavour of the company to create an enabling workforce for ...
Watch: Honda Activa 125 BS-VI review
The Activa 125 witnesses a hike of Rs 6,500 to Rs 9,000 (depending on the variant) over the previous generation. The standard variant, which...
Comments
4/recentcomments
Categories
Business News: Latest News on Business
Companies
Financial News
India Business & World Business News
Moneycontrol Business News
Stock Markets
Powered by
Blogger
.
No comments: